Scientists hunt for early clues to stop deadly treatment reactions
NCT ID NCT06377059
Summary
This study aims to better predict which blood cancer patients are at high risk for dangerous side effects, like cytokine release syndrome (CRS), after receiving immunotherapy. Researchers will monitor 100 patients continuously with wireless sensors and blood tests to look for early warning signs in their vital signs and immune responses. The goal is to build a model that helps doctors identify patients who need closer hospital monitoring so complications can be caught and treated sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rigshospitalet
RECRUITINGCopenhagen O, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.